Paclieva 300mg

Paclieva 300mg Injection is a chemotherapy drug that contains the active ingredient paclitaxel. It is utilized for the treatment of breast cancer, non-small cell lung cancer, ovarian cancer, and Kaposi’s sarcoma associated with AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is characterized by the rapid and uncontrolled division and growth of cells. This medication is not advised for adolescents and children under 18 years of age.

Paclieva 300mg Injection can be administered on its own or in conjunction with other anticancer therapies. This chemotherapy drug is contraindicated for individuals with severe liver issues, uncontrolled infections, or low counts of white blood cells or platelets. Consult your physician if you have any heart conditions prior to using this medication.

The administration of this drug may lead to severe allergic reactions. It is important to use effective contraception during treatment and for at least six months following the final dose. Paclieva 300mg Injection may pose risks to patients with a history of alcoholism, as it contains alcohol.